Rats think of objects and places that are not directly in front of them, a key r...
This week on "The Readout LOUD" podcast: When is a failure not a failure? Does t...
In a small trial, 63% of kidney transplant patients were able to discontinue imm...
A bipartisan bill would permanently extend a Covid-era policy that allowed patie...
Camidanlumab tesirine is under clinical development by ADC Therapeutics and curr...
AB-1003 is under clinical development by Asklepios BioPharmaceutical and current...
Darovasertib is under clinical development by Ideaya Biosciences and currently i...
GRWD-5769 is under clinical development by Grey Wolf Therapeutics and currently ...
APVO-436 is under clinical development by Aptevo Therapeutics and currently in P...
PRT-811 is under clinical development by Prelude Therapeutics and currently in P...
Bezuclastinib is under clinical development by Cogent Biosciences and currently ...
Rituximab biosimilar is under clinical development by Celltrion and currently in...
Gebasaxturev is under clinical development by Merck and currently in Phase II fo...
ALG.APV-527 is under clinical development by Alligator Bioscience and currently ...
An important Phase 3 trial has shown that a new drug that targets gonorrhea work...
Sarepta Therapeutics celebrated the results of a clinical trial of its Duchenne ...